Literature DB >> 31580932

Elite athletes on regular training show more pronounced induction of vaccine-specific T-cells and antibodies after tetravalent influenza vaccination than controls.

Alexandra Ledo1, David Schub1, Clemens Ziller2, Martin Enders3, Tanja Stenger2, Barbara C Gärtner4, Tina Schmidt1, Tim Meyer2, Martina Sester5.   

Abstract

Compliance of elite athletes with vaccination recommendations is low mainly based on concerns about side-effects and perceived poor vaccine efficacy due to continued physical training. We therefore employed seasonal influenza vaccination to investigate the effect of regular physical training on vaccine-induced cellular and humoral immunity in elite athletes and controls. Lymphocyte subpopulations and vaccine-specific T-cells were quantified and functionally characterized from 45 athletes and 25 controls before, and 1, 2 and 26 weeks after vaccination. Moreover, influenza-specific antibodies and their neutralizing function were quantified. Both groups showed a significant increase in vaccine-reactive CD4 T-cell levels which peaked one week after vaccination (p < 0.0001). The increase was significantly more pronounced in athletes (4.1-fold) compared to controls (2.3-fold; p = 0.0007). The cytokine profile changed from multifunctional T-cells co-producing IFNγ, IL-2 and TNFα to cells with restricted cytokine expression. This change in functionality was associated with a significant increase in CTLA-4 expression (p < 0.0001), which again was more pronounced in athletes. Likewise, the increase in neutralizing antibodies was stronger in athletes (p = 0.004 for H1N1; p = 0.032 for H3N2). In conclusion, both groups mounted a strong vaccine-specific cellular and humoral immunity after standard vaccination. The more pronounced increase in specific T-cells and neutralizing antibodies indicates that high frequency and intensity of training enhance vaccine-responses in elite athletes.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cellular immunity; Competitive sports; Exercise; Humoral immunity; Influenza; Neutralizing antibodies; Physical activity; T cells; Vaccination

Mesh:

Substances:

Year:  2019        PMID: 31580932     DOI: 10.1016/j.bbi.2019.09.024

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  9 in total

1.  Physical activity and acute exercise benefit influenza vaccination response: A systematic review with individual participant data meta-analysis.

Authors:  Erika Bohn-Goldbaum; Katherine B Owen; Vivian Y J Lee; Robert Booy; Kate M Edwards
Journal:  PLoS One       Date:  2022-06-15       Impact factor: 3.752

Review 2.  Effects of Exercise and Physical Activity Levels on Vaccination Efficacy: A Systematic Review and Meta-Analysis.

Authors:  Petros C Dinas; Yiannis Koutedakis; Leonidas G Ioannou; George Metsios; George D Kitas
Journal:  Vaccines (Basel)       Date:  2022-05-12

Review 3.  Baseline physical activity is associated with reduced mortality and disease outcomes in COVID-19: A systematic review and meta-analysis.

Authors:  Masoud Rahmati; Mahdieh Molanouri Shamsi; Kayvan Khoramipour; Fatemeh Malakoutinia; Wongi Woo; Seoyeon Park; Dong Keon Yon; Seung Won Lee; Jae Il Shin; Lee Smith
Journal:  Rev Med Virol       Date:  2022-04-13       Impact factor: 11.043

Review 4.  Coronavirus disease-2019: A tocsin to our aging, unfit, corpulent, and immunodeficient society.

Authors:  David C Nieman
Journal:  J Sport Health Sci       Date:  2020-05-08       Impact factor: 7.179

Review 5.  Why Physical Activity Should Be Considered in Clinical Trials for COVID-19 Vaccines: A Focus on Risk Groups.

Authors:  Miguel Junior Sordi Bortolini; Bernardo Petriz; José Roberto Mineo; Rafael de Oliveira Resende
Journal:  Int J Environ Res Public Health       Date:  2022-02-07       Impact factor: 3.390

6.  Small steps, strong shield: directly measured, moderate physical activity in 65 361 adults is associated with significant protective effects from severe COVID-19 outcomes.

Authors:  Lizelle Steenkamp; Robin Terence Saggers; Rossella Bandini; Saverio Stranges; Yun-Hee Choi; Jane S Thornton; Simon Hendrie; Deepak Patel; Shannon Rabinowitz; Jon Patricios
Journal:  Br J Sports Med       Date:  2022-02-09       Impact factor: 18.473

7.  Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens.

Authors:  Verena Klemis; Tina Schmidt; David Schub; Janine Mihm; Stefanie Marx; Amina Abu-Omar; Laura Ziegler; Franziska Hielscher; Candida Guckelmus; Rebecca Urschel; Stefan Wagenpfeil; Sophie Schneitler; Sören L Becker; Barbara C Gärtner; Urban Sester; Martina Sester
Journal:  Nat Commun       Date:  2022-08-11       Impact factor: 17.694

Review 8.  Recent advances in influenza vaccines.

Authors:  Graham Pawelec; Janet McElhaney
Journal:  F1000Res       Date:  2020-04-28

9.  Cytotoxic T-cells mediate exercise-induced reductions in tumor growth.

Authors:  Helene Rundqvist; Pedro Veliça; Laura Barbieri; Paulo A Gameiro; David Bargiela; Milos Gojkovic; Sara Mijwel; Stefan Markus Reitzner; David Wulliman; Emil Ahlstedt; Jernej Ule; Arne Östman; Randall S Johnson
Journal:  Elife       Date:  2020-10-23       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.